BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31602798)

  • 1. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
    Koh HM; Kim DC; Kim YM; Song DH
    Thorac Cancer; 2019 Dec; 10(12):2209-2217. PubMed ID: 31602798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
    He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
    World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
    Wang SS; Zheng M; Pang X; Zhang M; Yu XH; Wu JB; Gao XL; Wu JS; Yang X; Tang YJ; Tang YL; Liang XH
    Mol Carcinog; 2019 Oct; 58(10):1809-1821. PubMed ID: 31219646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
    Pei XJ; Wu TT; Li B; Tian XY; Li Z; Yang QX
    Int J Med Sci; 2014; 11(1):106-15. PubMed ID: 24396292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.
    Goto A; Tanaka M; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Kuriyama S; Konno H; Imai K; Saito H; Minamiya Y; Maeda D
    PLoS One; 2017; 12(7):e0181270. PubMed ID: 28704499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance.
    Tomiyasu M; Yoshino I; Suemitsu R; Okamoto T; Sugimachi K
    Clin Cancer Res; 2002 Dec; 8(12):3755-60. PubMed ID: 12473586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.
    Ren Y; Law S; Huang X; Lee PY; Bacher M; Srivastava G; Wong J
    Ann Surg; 2005 Jul; 242(1):55-63. PubMed ID: 15973102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
    Zeng J; Quan J; Xia X
    Mol Med Rep; 2016 Jan; 13(1):174-80. PubMed ID: 26549761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of MIF and CD147 in non-small cell lung cancer].
    Liu Q; Yang H; Zhang SF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):85-90. PubMed ID: 20369477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.
    Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM
    Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
    Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
    Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.
    Cheng RJ; Deng WG; Niu CB; Li YY; Fu Y
    Int J Gynecol Cancer; 2011 Aug; 21(6):1004-12. PubMed ID: 21792010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of macrophage migration inhibitory factor in invasion of ovarian cancer].
    Wu HM; Zhu SL; He LJ; Liu YH; Xie D
    Ai Zheng; 2009 Oct; 28(10):1054-60. PubMed ID: 19799813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
    Kindt N; Preillon J; Kaltner H; Gabius HJ; Chevalier D; Rodriguez A; Johnson BD; Megalizzi V; Decaestecker C; Laurent G; Saussez S
    J Cancer Res Clin Oncol; 2013 May; 139(5):727-37. PubMed ID: 23354841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma].
    Guo YS; Dai YP; Li W; Liu LD
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):28-31. PubMed ID: 21575460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF‑κB/HIF‑1α pathway in lung cancer.
    Li J; Zhang J; Xie F; Peng J; Wu X
    Int J Mol Med; 2018 Feb; 41(2):1062-1068. PubMed ID: 29207023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
    Oliveira CS; de Bock CE; Molloy TJ; Sadeqzadeh E; Geng XY; Hersey P; Zhang XD; Thorne RF
    BMC Cancer; 2014 Aug; 14():630. PubMed ID: 25168062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
    Wang D; Wang R; Huang A; Fang Z; Wang K; He M; Xia JT; Li W
    Oncol Rep; 2018 Nov; 40(5):2628-2636. PubMed ID: 30226561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.